1. Market Research
  2. > Healthcare Market Trends
  3. > Kenya Pharmaceuticals and Healthcare Report Q4 2016

Kenya Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 87 pages

Includes 3 FREE quarterly updates


BMI View:

It is vital that companies that are looking to sell non-communicable disease therapeutics work alongside the public sector and focus on physician education and patient awareness in a market that has traditionally focussed on infectious diseases such as malaria, tuberculosis and HIV. Besides challenges related to diagnosis, care and treatment, there is a lack of understanding and knowledge about diseases such as diabetes and cardiovascular disease among healthcare professionals and the general population, and a perception that such diseases are not as critical as other diseases affecting the country. Headline Expenditure Projections

- Pharmaceuticals: KES73.34bn (USD750mn) in 2015 to KES84.04bn (USD830mn) in 2016; 14.6% growth in local currency terms and 10.8% in US dollar terms.

- Healthcare: KES341.18bn (USD3.47bn) in 2015 to KES377.30 (USD3.71bn) in 2016; 10.6% growth in local currency terms and 7.0% in US dollar terms.

Table Of Contents

Kenya Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kenya 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kenya 2012-2020) 11
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 21
OTC Medicines Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Kenya 2014-2020) 25
Table: Pharmaceutical Trade Data And Forecasts local currency (Kenya 2014-2020) 26
Industry Risk Reward Index 27
Middle East and Africa Risk/Reward Index - Q4 2016 27
Kenya Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 38
Pricing and Reimbursement Regime 38
Market Overview 40
Healthcare Sector 40
Table: Healthcare Resources (Kenya 2010-2015) 42
Table: Healthcare Personnel (Kenya 2010-2015) 42
Table: Healthcare Activity (Kenya 2010-2015) 43
Research and Development 50
Clinical Trials 52
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 62
Company Profile 63
GlaxoSmithKline 63
Merck and Co 66
Novartis 68
Pfizer 71
Sanofi 74
Demographic Forecast 76
Table: Population Headline Indicators (Kenya 1990-2025) 77
Table: Key Population Ratios (Kenya 1990-2025) 77
Table: Urban/Rural Population and Life Expectancy (Kenya 1990-2025) 78
Table: Population By Age Group (Kenya 1990-2025) 78
Table: Population By Age Group % (Kenya 1990-2025) 79
Glossary 81
Methodology 83
Pharmaceutical Expenditure Forecast Model 83
Healthcare Expenditure Forecast Model 83
Notes On Methodology 84
Risk/Reward Index Methodology 85
Index Overview 86
Table: Pharmaceutical Risk/Reward Index Indicators 86
Indicator Weightings 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The wound care market in terms of value is expected to reach USD 20.4 billion by 2021 from USD 17.0 billion in 2016, growing at a CAGR of 3.6% from 2016 to 2021. This market is categorized on the basis ...

Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

Adhesion Barrier Market by Product, Product Form, Application - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global adhesion barriers market is expected to grow at a CAGR of 8.4% during the forecast period of 2016 to 2021. This market is projected to reach USD 1,216.8 million by 2021 from USD 812.5 million ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.